De-biotech and STMicroelectronics have announced a strategic agreement to manufacture and market a unique miniature insulin pump. It is reported that this nano-pump is an innovative concept based on microfluidic MEMS (micro-electromechanical systems) technology, the design principle is to install a micro-injection pump on a one-time skin patch to patients with diabetes continuous infusion of insulin. The product's original technology won the 2006 Swiss Technology Award. Insulin pump therapy or continuous subcutaneous injections of insulin (CSII) can replace a single injection several times a day insulin injection alone, this therapy is more and more people are optimistic. This highly miniaturized disposable insulin pump combines Debiotech's insulin infusion technology with ST's mass-production microfluidic chip manufacturing capabilities. The new Debiotech miniaturized MEMS product manufactured by ST, measuring approximately one-fourth the size of existing syringe pumps, accurately controls the amount of insulin required by a physician and achieves nanoliter control of liquid infusion, Very close to human insulin infusion. The product can prevent overdose, detect inadequate medications in the syringe pump, blockage, air bubbles and other potential failures to further protect the patient. In addition, the costs are so low that patients or healthcare systems do not have to pay for the up-front investment common to existing syringe pump solutions.